Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |